Position in PFE
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$21,242,774
-$1,235,406 QoQ
Shares Held
882,175
+10.2% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#276
of 2,821 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ethic Inc. holds $332,739,634 across 14 Drug Manufacturers - General names. PFE ranks #4 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
90,920 | $109,052,184 | |
| 2 | MRK |
Merck & Co., Inc.
|
358,041 | $46,008,268 | |
| 3 | JNJ |
Johnson & Johnson
|
109,758 | $27,875,239 | |
| 4 | PFE |
Pfizer Inc
This page
|
882,175 | $21,242,774 | |
| 5 | ABBV |
AbbVie Inc.
|
83,563 | $21,027,793 | |
| 6 | AMGN |
Amgen Inc
|
56,184 | $20,345,350 | |
| 7 | NVS |
Novartis AG
|
108,784 | $17,048,628 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
270,904 | $15,609,488 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,242,774 | 882,175 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $22,478,180 | 800,505 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $17,901,556 | 718,938 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $18,268,166 | 716,961 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $18,527,334 | 764,329 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $16,306,670 | 643,515 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $11,924,545 | 449,474 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,263,491 | 320,093 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $10,336,763 | 369,434 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,882,580 | 320,093 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $11,063,795 | 384,293 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,136,414 | 396,033 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,253,841 | 361,337 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,464,938 | 330,023 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,017,009 | 215,008 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,285,945 | 120,794 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,158,380 | 79,313 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,972,022 | 38,092 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,157,025 | 19,594 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $929,188 | 21,604 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $747,055 | 19,077 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $661,777 | 18,266 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $737,267 | 20,029 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $705,593 | 19,226 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $260,128 | 7,955 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||